The latest closing stock price for Brainstorm Cell Therapeutics as of November 20, 2024 is 1.26.
An investor who bought $1,000 worth of Brainstorm Cell Therapeutics stock at the IPO in 2003 would have $-990 today, roughly -1 times their original investment - a -19.62% compound annual growth rate over 21 years.
The all-time high Brainstorm Cell Therapeutics stock closing price was 776.29 on January 07, 2005.
The Brainstorm Cell Therapeutics 52-week high stock price is 11.88, which is 842.9% above the current share price.
The Brainstorm Cell Therapeutics 52-week low stock price is 1.05, which is 16.7% below the current share price.
The average Brainstorm Cell Therapeutics stock price for the last 52 weeks is 5.07.
An investor who bought $1,000 worth of Brainstorm Cell Therapeutics stock at the IPO in 2003 would have $-990 today, roughly -1 times their original investment - a -19.62% compound annual growth rate over 21 years.
The all-time high Brainstorm Cell Therapeutics stock closing price was 776.29 on January 07, 2005.
The Brainstorm Cell Therapeutics 52-week high stock price is 11.88, which is 842.9% above the current share price.
The Brainstorm Cell Therapeutics 52-week low stock price is 1.05, which is 16.7% below the current share price.
The average Brainstorm Cell Therapeutics stock price for the last 52 weeks is 5.07.